The incidence of multidrug-resistant tuberculosis (MDR-TB) is increasing in high human immunodeficiency virus (HIV) prevalence settings, with high associated mortality. Treatment outcomes in HIV-co-infected adults and children are poorly documented
Background: Little is known about the treatment of multidrug-resistant tuberculosis (MDR-TB) in HIV-...
Multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) represent an emerging pub...
Background The emergence of resistance to anti-tuberculosis (DR-TB) drugs and the HIV epidemic repre...
Few studies have examined outcomes for children treated for multidrug-resistant tuberculosis (MDR-TB...
BACKGROUND: Few studies have examined outcomes for children treated for multidrug-resistant tubercul...
The aim of this study was to find out whether human immunodeficiency virus (HIV)-infection and antir...
BackgroundMultidrug-resistant or rifampicin-resistant tuberculosis (MDR/RR-TB) and human immunodefic...
BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) in HIV endemic settings is a major threat to p...
The aim of this study was to find out whether human immunodeficiency virus (HIV)-infection and antir...
BACKGROUND: Although the importance of concurrent treatment for multidrug-resistant tuberculosis (MD...
Although the importance of concurrent treatment for multidrug-resistant tuberculosis (MDR-TB) and HI...
Multidrug-resistant tuberculosis (MDR-TB) is a major clinical challenge, particularly in patients wi...
Background: Few studies have examined outcomes for children treated for multidrug-resistant tubercul...
Background Programs that integrate tuberculosis (TB) and human immunodeficiency virus (HIV) treatme...
BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) in HIV endemic settings is a major threat to p...
Background: Little is known about the treatment of multidrug-resistant tuberculosis (MDR-TB) in HIV-...
Multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) represent an emerging pub...
Background The emergence of resistance to anti-tuberculosis (DR-TB) drugs and the HIV epidemic repre...
Few studies have examined outcomes for children treated for multidrug-resistant tuberculosis (MDR-TB...
BACKGROUND: Few studies have examined outcomes for children treated for multidrug-resistant tubercul...
The aim of this study was to find out whether human immunodeficiency virus (HIV)-infection and antir...
BackgroundMultidrug-resistant or rifampicin-resistant tuberculosis (MDR/RR-TB) and human immunodefic...
BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) in HIV endemic settings is a major threat to p...
The aim of this study was to find out whether human immunodeficiency virus (HIV)-infection and antir...
BACKGROUND: Although the importance of concurrent treatment for multidrug-resistant tuberculosis (MD...
Although the importance of concurrent treatment for multidrug-resistant tuberculosis (MDR-TB) and HI...
Multidrug-resistant tuberculosis (MDR-TB) is a major clinical challenge, particularly in patients wi...
Background: Few studies have examined outcomes for children treated for multidrug-resistant tubercul...
Background Programs that integrate tuberculosis (TB) and human immunodeficiency virus (HIV) treatme...
BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) in HIV endemic settings is a major threat to p...
Background: Little is known about the treatment of multidrug-resistant tuberculosis (MDR-TB) in HIV-...
Multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) represent an emerging pub...
Background The emergence of resistance to anti-tuberculosis (DR-TB) drugs and the HIV epidemic repre...